Literature DB >> 10372115

Retroviral-fibronectin interactions in transduction of mammalian cells.

D A Williams1.   

Abstract

Hematopoiesis occurs in a complex environment in the medullary cavity in close proximity to stromal cells, fibroblasts, endothelial cells and matrix molecules. Hematopoietic cell interactions in this environment appear to involve both integrin and proteoglycan-mediated cell-cell and cell-matrix interactions. Genetic transduction of hematopoietic stem cells via retroviral vectors has been hampered by low efficiency of gene transfer. Recently, hematopoietic stem cell adhesion to the extracellular matrix molecule fibronectin has been shown to increase transduction of these target cells using retrovirus vectors. The mechanism of increased transduction appears to involve colocalization of virus particles and target cells. These data are reviewed in this paper.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372115     DOI: 10.1111/j.1749-6632.1999.tb08457.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach.

Authors:  Tatiana Segura; Peter H Chung; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

2.  Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID.

Authors:  Alessandro Aiuti; Immacolata Brigida; Francesca Ferrua; Barbara Cappelli; Robert Chiesa; Sarah Marktel; Maria-Grazia Roncarolo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors.

Authors:  Rui-Jun Su; David J Baylink; Amanda Neises; Jason B Kiroyan; Xianmei Meng; Kimberly J Payne; Benjamin Tschudy-Seney; Yuyou Duan; Nancy Appleby; Mary Kearns-Jonker; Daila S Gridley; Jun Wang; K-H William Lau; Xiao-Bing Zhang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.